Clinical Trials Logo

Anaphylaxis Food clinical trials

View clinical trials related to Anaphylaxis Food.

Filter by:
  • None
  • Page 1

NCT ID: NCT05696236 Recruiting - Anaphylaxis Food Clinical Trials

Predicting Peanut Anaphylaxis and Reducing Epinephrine

PrePARE
Start date: May 23, 2023
Phase: N/A
Study type: Interventional

This research study is testing a new way to look for the early stages of anaphylaxis. Eligible participants will have a small monitor (transepidermal water loss) placed on the forearm during a food challenge (for peanut allergies). This monitor continuously records the amount of water lost through the skin. In a previous study the team learned what values are associated with an anaphylactic reaction. These values are called "stopping rules." This study is looking at whether it can use these new stopping rules to end the oral food challenge before a person may show any symptoms.

NCT ID: NCT03487315 Completed - Wheat Allergy Clinical Trials

Major Allergen in Wheat Anaphylaxis in Thai Population

Start date: April 5, 2017
Phase: N/A
Study type: Interventional

- To study Major allergen in Wheat anaphylaxis in Thai population - To study and compare demographic data between group of wheat anaphylaxis

NCT ID: NCT03149315 Completed - Food Allergy Clinical Trials

Inhibition of Anaphylaxis by Ibrutinib

Start date: April 10, 2017
Phase: Phase 2
Study type: Interventional

This is a phase II open label study on the use of Ibrutinib on the inhibition of food-induced anaphylaxis in adults with food allergy. Ibrutinib (brand name Imbruvica) is currently FDA approved for the treatment of mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and Waldenstrom's macroglobulineia (WM). We propose to administer this approved drug to adults with food allergy to inhibit food allergy responses.